ResearcherFirst Affiliated Hospital Zhejiang UniversityActive in the last 2 years
Xiaobao Wei
Matched on OpenAlex author ID A5030979847. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2024: 1 paper · 2025: 2 papers
Papers 3
- Nano-enabled repurposing of Benproperine phosphate enhances pancreatic Cancer chemotherapy through lethal autophagy arrest and immune activation. Co-author DOI 10.1016/j.jconrel.2025.114187↗
- A novel FAP-targeting antibody-exatecan conjugate improves immune checkpoint blockade by reversing immunosuppressive microenvironment in pancreatic cancer. Co-author DOI 10.1038/s41388-025-03567-x↗
- IFNα-induced BST2+ tumor-associated macrophages facilitate immunosuppression and tumor growth in pancreatic cancer by ERK-CXCL7 signaling. Co-author DOI 10.1016/j.celrep.2024.114088↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jiangchao Wu · 3 shared papers, 2024–2025 · strength 0.61
- Paper A novel FAP-targeting antibody-exatecan conjugate improves immune checkpoint blockade by reversing immunosuppressive mi… DOI 10.1038/s41388-025-03567-x↗
- Paper Nano-enabled repurposing of Benproperine phosphate enhances pancreatic Cancer chemotherapy through lethal autophagy arr… DOI 10.1016/j.jconrel.2025.114187↗
- Paper IFNα-induced BST2+ tumor-associated macrophages facilitate immunosuppression and tumor growth in pancreatic cancer by E… DOI 10.1016/j.celrep.2024.114088↗
- Tingbo Liang · 3 shared papers, 2024–2025 · strength 0.61
- Paper A novel FAP-targeting antibody-exatecan conjugate improves immune checkpoint blockade by reversing immunosuppressive mi… DOI 10.1038/s41388-025-03567-x↗
- Paper Nano-enabled repurposing of Benproperine phosphate enhances pancreatic Cancer chemotherapy through lethal autophagy arr… DOI 10.1016/j.jconrel.2025.114187↗
- Paper IFNα-induced BST2+ tumor-associated macrophages facilitate immunosuppression and tumor growth in pancreatic cancer by E… DOI 10.1016/j.celrep.2024.114088↗
- Qi Zhang · 1 shared paper, 2025 · strength 0.23
- Mengyao Dai · 1 shared paper, 2025 · strength 0.20
- Zhe Zhang · 1 shared paper, 2025 · strength 0.20
- Yi Zang · 1 shared paper, 2025 · strength 0.20
- Qi Zhang · 1 shared paper, 2025 · strength 0.20
- Junli Wang · 1 shared paper, 2024 · strength 0.18
- Yi Duan · 1 shared paper, 2024 · strength 0.18
- Yunhua Liu · 1 shared paper, 2024 · strength 0.18
- Chenlei Zheng · 1 shared paper, 2024 · strength 0.18
- Mao Ye · 1 shared paper, 2024 · strength 0.18
- Bo Kong · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.